Local ablative therapy vs. systemic therapy for patients with oligometastatic disease
Joachim Widder • 16 May 2022
Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Keep up to date with all the latest news with our monthly newsletter